References
- Hussein M, Molina MA, Berkhout B, et al. A CRISPR-Cas cure for HIV/AIDS. Int J Mol Sci. 2023;24(2):1–15.
- Pauza CD, Huang K, Bordon J. Advances in cell and gene therapy for HIV disease: it is good to be specific. Curr Opin HIV AIDS. 2021;16(2):83–87. https://www.nature.com/articles/s41591-021-01590-5
- Yang S, Su B, Zhang X, et al. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: challenges of immunological non-responders. J Leukoc Biol. 2020;107(4):597–612.
- Kanazawa J, Gianella S, Concha-Garcia S, et al. Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: a qualitative study with key stakeholders in the United States. BMC Med Ethics. 2021;23(1):2.
- Engler K, Lessard D, Lebouché B. A review of HIV-specific patient-reported outcome measures. Patient. 2017;10(2):187–202.
- Dubé K, Perez-Brumer A. Call for justice-informed HIV cure trials with ATIs. Lancet HIV. 2024:1–2; [cited 2024 Jan]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S235230182400002X
- People First Charter; [cited 2024 Feb 19]. Available from: https://peoplefirstcharter.org/.
- Dubé K, Kanazawa JT, Campbell C, et al. Considerations for increasing racial, ethnic, gender and sexual diversity in HIV cure-related research with analytical treatment interruptions: a qualitative inquiry. AIDS Res Hum Retroviruses. 2022;38(1):50–63.
- Namiba A, Kwardem L, Dhairyawan R, et al. From presumptive exclusion towards fair inclusion: perspectives on the involvement of women living with HIV in clinical trials, including stakeholders’ views. Vol 9, Therapeutic advances in infectious disease. SAGE Publications Ltd; 2022. p. 1–17.
- Dubé K, Barr E, Philbin M, et al. Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States. HIV Res Clin Pract. 2023;24(1):2246717.